Working with rare disease populations requires compliance strategies be thought through strategically in advance. Small populations, like those found in rare and ultra-rare disease populations can increase the likelihood of patient re-identification if advanced methods are not applied. This webinar session will focus on learnings and best practices to apply when working with rare disease trials and populations.
View On-Demand Here: Trial Disclosure: A Focus on Rare Disease
Speakers:
